Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2025 Jul 29;11(4):e200295.
doi: 10.1212/NXG.0000000000200295. eCollection 2025 Aug.

Untangling Complexity in Dysferlinopathy With MRI Modeling of Disease Trajectory

Jasper M Morrow  1
Affiliations
Editorial

Untangling Complexity in Dysferlinopathy With MRI Modeling of Disease Trajectory

Jasper M Morrow. Neurol Genet. .
No abstract available

PubMed Disclaimer

Conflict of interest statement

J.M. Morrow served on a scientific advisory board and as consultant for Roche and has received research funding from Applied Therapeutics, not related to the submitted manuscript. Go to Neurology.org/NG for full disclosures.

Comment in

  • Modeling of Dysferlinopathy (LGMDR2) Progression: A Longitudinal Fat Fraction Analysis.
    Bolano-Diaz CF, Reyngoudt H, Wilson IJ, James MK, Smith FE, Caldas de Almeida Araujo E, Gordish-Dressman H, Hilsden H, Rufibach LE, Wallace D, Ward L, Stramare R, Rampado A, Smith M, Boisserie JM, Le Louer J, Foster S, Peduto A, Sato N, Tamaru T, Sawyer AM, Day JW, Jones KJ, Walter MC, Stojkovic T, Mori-Yoshimura M, Mendell JR, Pegoraro E, Straub V, Blamire AM, Carlier P, Diaz-Manera J; Jain COS Consortium. Bolano-Diaz CF, et al. Neurol Genet. 2025 Jul 29;11(4):e200283. doi: 10.1212/NXG.0000000000200283. eCollection 2025 Aug. Neurol Genet. 2025. PMID: 40740171 Free PMC article.

References

    1. Moore UR, Jacobs M, Fernandez-Torron R, et al. Teenage exercise is associated with earlier symptom onset in dysferlinopathy: a retrospective cohort study. J Neurol Neurosurg Psychiatry. 2018;89(11):1224–1226. doi: 10.1136/JNNP-2017-317329 - DOI - PMC - PubMed
    1. Poudel BH, Fletcher S, Wilton SD, Aung-Htut M. Limb girdle muscular dystrophy type 2B (LGMD2B): diagnosis and therapeutic possibilities. Int J Mol Sci. 2024;25(11):5572. doi: 10.3390/IJMS25115572 - DOI - PMC - PubMed
    1. Rooney WD, Berlow YA, Triplett WT, et al. Modeling disease trajectory in Duchenne muscular dystrophy. Neurology. 2020;94(15):E1622-E1633. doi: 10.1212/WNL.0000000000009244 - DOI - PMC - PubMed
    1. Bolano-Diaz CF, Reyngoudt H, Wilson IJ. Modelling of dysferlinopathy (LGMD R2) progression: a longitudinal fat fraction analysis. Neurol Genet. 2025;11(4):e200283. doi: 10.1212/NXG.0000000000200283 - DOI - PMC - PubMed
    1. Harris E, Bladen CL, Mayhew A, et al. The clinical outcome study for dysferlinopathy an international multicenter study. Neurol Genet. 2016;2(4):e89. doi: 10.1212/NXG.0000000000000089 - DOI - PMC - PubMed

Publication types

LinkOut - more resources